Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation
© Anderson et al; licensee BioMed Central Ltd. 2010
Received: 13 November 2009
Accepted: 9 December 2010
Published: 9 December 2010
Intestinal barrier function is important for preserving health, as a compromised barrier allows antigen entry and can induce inflammatory diseases. Probiotic bacteria can play a role in enhancing intestinal barrier function; however, the mechanisms are not fully understood. Existing studies have focused on the ability of probiotics to prevent alterations to tight junctions in disease models, and have been restricted to a few tight junction bridging proteins. No studies have previously investigated the effect of probiotic bacteria on healthy intestinal epithelial cell genes involved in the whole tight junction signalling pathway, including those encoding for bridging, plaque and dual location tight junction proteins. Alteration of tight junction signalling in healthy humans is a potential mechanism that could lead to the strengthening of the intestinal barrier, resulting in limiting the ability of antigens to enter the body and potentially triggering undesirable immune responses.
The effect of Lactobacillus plantarum MB452 on tight junction integrity was determined by measuring trans-epithelial electrical resistance (TEER) across Caco-2 cell layers. L. plantarum MB452 caused a dose-dependent TEER increase across Caco-2 cell monolayers compared to control medium. Gene expression was compared in Caco-2 cells untreated or treated with L. plantarum MB452 for 10 hours. Caco-2 cell RNA was hybridised to human oligonucleotide arrays. Data was analysed using linear models and differently expressed genes were examined using pathway analysis tools. Nineteen tight junction-related genes had altered expression levels in response to L. plantarum MB452 (modified-P < 0.05, fold-change > 1.2), including those encoding occludin and its associated plaque proteins that anchor it to the cytoskeleton. L. plantarum MB452 also caused changes in tubulin and proteasome gene expression levels which may be linked to intestinal barrier function. Caco-2 tight junctions were visualised by fluorescent microscopy of immuno-stained occludin, zona occludens (ZO)-1, ZO-2 and cingulin. Caco-2 cells treated with L. plantarum MB452 had higher intensity fluorescence of each of the four tight junction proteins compared to untreated controls.
This research indicates that enhancing the expression of genes involved in tight junction signalling is a possible mechanism by which L. plantarum MB452 improves intestinal barrier function.
The intestinal barrier is the largest interface between man and the external environment, and the maintenance of its integrity has an important role in preserving health. When intestinal barrier function is compromised, it can become "leaky" allowing pathogens and toxins to enter the body. The function of the intestinal barrier is compromised in human conditions such as Inflammatory Bowel Diseases (Crohn's Disease and Ulcerative Colitis) , Irritable Bowel Syndrome  and some kinds of food-borne infections . Moreover, intestinal barrier function can be temporarily impaired during times of stress  and it inevitably deteriorates with aging . In addition, increased intestinal permeability can also result in pathological changes in distant organs and tissues, which can lead to further complications in susceptible individuals such as asthma , chronic heart failure , type-1-diabetes , chronic fatigue syndrome  and depression .
A critical component of the intestinal barrier is the intercellular junction complexes between adjacent intestinal epithelial cells which form a semi-permeable diffusion barrier. These intercellular complexes consist of tight junctions, adherens junctions, desmosomes and gap junctions . The tight junctions are the most apical and are responsible for controlling the permeability of the paracellular pathway. Tight junctions are formed by protein dimers that span the space between adjacent cell membranes. There are over 40 proteins with well recognised roles in tight junction formation. These proteins can be divided into three functional categories: 1) bridge proteins which form a web between adjacent cell membranes; 2) plaque proteins which anchor bridge proteins to the actin cytoskeleton; and 3) dual location proteins which are not continuously associated with the tight junctions and also act as transcription factors.
The maintenance or enhancement of intestinal barrier function is a beneficial property that some probiotic bacteria exert. Some probiotics have been shown to ameliorate intestinal permeability induced by pathogens in vitro [12, 13]; whereas, others probiotic bacteria have been shown to enhance tight junction integrity between intestinal epithelial cells that are not weakened [13–15]. Existing mechanistic studies have focused on the ability of probiotics to prevent alterations to few tight junction bridging proteins in disease models, e.g. the effect of VSL#3 on dextran sodium sulphate-induced colitis in mice  and the effect of Lactobacillus plantarum CGMCC 1258 on Enteroinvasive E. coli ATCC 43893 (serotype O124:NM)-induced barrier disruption in vitro . The effect of probiotics on tight junction proteins in a healthy intestinal barrier have not been reported, nor the effect of probiotic bacteria on epithelial cell genes involved in the whole tight junction signalling pathway, including those encoding for bridging, plaque and dual location tight junction proteins. Alteration of tight junction signalling in healthy humans is a potential mechanism that could lead to the strengthening of the intestinal barrier, resulting in limiting the ability of antigens to enter the body and potentially triggering undesirable immune responses.
The hypothesis of this research was that probiotic bacteria that increase intestinal barrier function achieve this, partly, by increasing the expression of the genes involved in tight junction signalling in healthy intestinal epithelial cells. L. plantarum MB452 isolated from the probiotic product VSL#3 was chosen as the test bacterium because it has a robust, repeatable, positive effect tight junction integrity, as measured by the trans-epithelial electrical resistance (TEER) in vitro (unpublished results). VLS#3, which is a mixture of eight bacteria including L. plantarum MB452, has previously been reported to enhance tight junction integrity in vitro , reduce colitis in rodent models [19, 20] and improve human intestinal health [21–23]. The effect of L. plantarum MB452 on intestinal epithelial cells was investigated in vitro using human colon cancer cells (Caco-2 cells), a commonly used model of the intestinal epithelium that spontaneously form tight junctions between adjacent cells, and trans-epithelial electrical resistance assays, whole genome microarray analysis, and fluorescent microscopy of tight junction proteins.
Effect of L. plantarum MB452 on TEER was dose-dependent
The drop in TEER for all treatments between 0 and 2 hours observed in all assays was likely due to the Caco-2 cell monolayers being disturbed by the change in media during the sample addition after the initial readings. The increase in TEER over time for the control Caco-2 cells was likely due to an increase in nutrient availability after the fresh media was added at the beginning of the experiment. The increases in TEER caused by L. plantarum MB452 were additional to those observed with fresh media.
L. plantarum MB452 altered the expression of genes involved tight junction formation
The ability of L. plantarum MB452 to alter gene expression in intestinal epithelial cells was measured using global gene expression analysis. The analysis indicated that 1,181 Caco-2 cell genes were differentially expressed (fold change > 1.2, modified-P < 0.05) when co-cultured with L. plantarum MB452; the expression levels of 554 genes were increased and 627 genes were decreased. The relatively low fold-change cut-off of 1.2 was selected because the comparison was between untreated healthy cells and healthy cells treated with potential beneficial bacteria so large differences (as seen when comparing healthy cells to a disease model) were not expected. The ten Ingenuity Pathway Analysis (IPA) functional groups with the most differentially expressed genes and the Gene Ontology categories with the lowest P-values are summarised in Additional File 1 Tables S1 and S2.
Caco-2 cell genes involved in intracellular junction complex formation that were differentially expressed in the microarray analysis after co-culturing with L. plantarum MB452 (OD600 nm 0.9) for 10 hours.
Description of role in relation to tight junctions
tight junction bridging protein
vascular endothelial growth factor A
cytokine that indirectly regulates tight junction formation and strengthening
structural constituent of cytoskeleton
tight junction plaque protein associated with occludin
par-6 partitioning defective 6 homolog beta
tight junction plaque protein associated with claudins and involved in cell polarization
actin alpha cardiac muscle 1
structural constituent of cytoskeleton
itchy homolog E3 ubiquitin protein ligase
ubiquitin-ligase molecule that regulates occludin degradation
major cytoplasmic protein that forms a complex with cadherins
CNKSR family member 3
tight junction plaque protein associated with JAMs
snail homolog 1
intracellular component that indirectly inhibits occuldin production
hepatocyte nuclear factor 4 alpha
transcription regulator that acts on occuldin
zona occludens 1 (tight junction protein 1)
tight junction plaque protein associated with occludin, JAMs and claudins
zona occludens 2 (tight junction protein 2)
tight junction plaque protein associated with occludin and claudins that acts as a guanylate kinase and also found in the nucleus
scaffolding molecule that regulates the actin cytoskeleton
membrane associated guanylate kinase 3
tight junction plaque protein a and guanylate kinase
membrane protein, palmitoylated 5
tight junction plaque protein associated with claudins and guanylate kinase involved in tight junction organization
cleavage and polyadenylation specific factor 2
transcription regulator that decreases tight junction stability
cyclin-dependent kinase 4
transcription regulator that decreases tight junction stability
Comparison between microarray and qRT-PCR analysis of Caco-2 cells genes after co-culturing with L. plantarum MB452 (OD600 nm 0.9) for 10 hours.
Microarray fold change
qRT-PCR fold change
L. plantarum MB452 altered the expression of other tight junction associated genes
Caco-2 cell tubulin and proteasome genes that were differentially expressed (modified-P < 0.05) in the microarray analysis after co-culturing with L. plantarum MB452 (OD600 nm 0.9) for 10 hours.
tubulin, alpha 1b
tubulin, alpha 1c
tubulin, alpha 3d
tubulin, alpha 4a
tubulin, beta 3
tubulin, beta 6
tubulin, beta 2c
proteasome, alpha subunit, 5
proteasome, beta subunit, 1
proteasome, beta subunit, 6
proteasome, beta subunit, 7
proteasome, 26 s subunit, 5
proteasome, 26 s subunit non-ATPase, 12
proteasome, activator subunit, 2
L. plantarum MB452 visually increased the abundance of tight junction proteins
As hypothesised, this study showed that L. plantarum MB452 altered the expression levels of tight junction-related genes in healthy intestinal epithelial cells. Of the tight junction bridging proteins, occludin mRNA abundance was higher in the presence of L. plantarum MB452. The over-expression of the occludin protein has been linked to increased TEER , and based on the findings of this study, increased occludin gene expression may contribute to the ability of L. plantarum MB452 to enhance tight junction integrity. In support of this, genes encoding for the occludin-associated plaque proteins, ZO-1 and ZO-2 and cingulin, also had increased expression levels in the presence of L. plantarum MB452. The zonula occludens bind to the cytoplasmic end of occludin and form the scaffolding to link occludin to the actin cytoskeleton . The increased expression levels of the occludin, ZO-1, ZO-2 and cingulin genes appeared to correlate with increased intensity of their proteins as indicated by the fluorescent microscopy images.
In contrast, other genes that had increased transcript levels in the presence of L. plantarum MB452 are known to be involved in tight junction disassembly. The gene encoding ITCH, an ubiquitin-ligase molecule, had increased expression levels in the presence of L. plantarum MB452; however, the ITCH protein is known to contribute to the degradation of occludin . The increased expression of the ITCH gene may lead to an increase in the turnover of occludin protein and, therefore, may have contributed to the increased occludin mRNA noted in this data. The gene encoding the SNAI1 protein also had increased expression in the presence of L. plantarum MB452; however, the SNAI1 protein is known to bind to occludin and claudin genes promoters suppressing their expression . Although these two genes, ITCH and SNAI1, have been linked to tight junction disassembly, 17 out of the 19 tight junction-related genes with increased expression levels in response to L. plantarum MB452 exposure contribute to tight junction stability; therefore, the cumulative effect would most likely be enhanced intestinal barrier function.
The 'tightness' of tight junctions is commonly thought to be, at least partly, due to claudins, which are a set of bridging proteins; however, none of the claudin genes were differentially expressed in response to L. plantarum MB452. Decreases in the abundance of claudin-2, -3 and -4 proteins (measured using western blotting) have been associated with a decrease in TEER . Another study showed that a decrease in TEER was associated with altered cellular localisation of claudin-1 and -5, but not altered abundance , so it is possible that L. plantarum MB452 may have altered the distribution of claudin proteins without changing gene expression and/or protein abundance.
The results of this study showed that L. plantarum MB452 enhanced the expression of 19 genes involved in the tight junction signalling pathway in healthy cells. A previous study showed that L. plantarum CGMCC 1258 is able to protect against the disruption of four tight junction proteins caused by Enteroinvasive E. coli ATCC 43893 (serotype O124:NM) . However, another study looking at the effect of L. plantarum ATCC202195 on the expression of genes in Caco-2 cells challenged with Enteroinvasive E. coli ATCC43893 (serotype O124:NM) did not report any changes in tight junction gene expression . This suggests that the L. plantarum protection against tight junction disruption was not due to it altering host gene expression, and was likely due to it inhibiting the action of the pathogen in that study.
The ability to enhance the expression of tight junction-related genes is not common to all L. plantarum strains. In addition to the study that showed that L. plantarum ATCC202195 nullifies changes in Caco-2 cell gene expression induced by Enteroinvasive E. coli ATCC43893 (serotype O124:NM) , other published studies investigating whole genome expression in response to L. plantarum have shown that, L. plantarum WCFSI induces increased expression of genes involved in lipid metabolism and cellular growth and development in healthy human duodenum  and L. plantarum (strain not given) alters the NF-κB pathway to limit inflammatory responses in healthy human duodenum . However, in these published studies only a few tight junction-related genes had altered expression levels when exposed to L. plantarum, for example increased expression of the ZO-2 gene, so they are unlikely to contribute to changes in tight junction integrity, compared to the changes in 19 tight junction genes induced by L. plantarum MB452 reported in this study. This is not surprising since strains of L. plantarum can have differing effects on intestinal barrier function in vitro, from neutral (cause no increase in TEER) to beneficial (cause substantial increase in TEER; unpublished results), and thus, it is likely that different strains may also have different effects on epithelial cell gene expression.
The observed increase in intestinal barrier function induced by L. plantarum MB452 may also be, at least partly, due to changes in intestinal epithelial cell gene expression that have an indirect effect on tight junction stability. Eight genes encoding for tubulins had lower expression levels in response to L. plantarum MB452. A high turnover in tubulin synthesis has been linked to the disassembly of tight junctions ; thus, the reduced expression levels of these genes may account for the positive effect of L. plantarum MB452 on intestinal barrier function. Similarly, seven genes encoding for proteasome subunits had lower mRNA abundance in the presence of L. plantarum MB452. Proteasomes, which are large protein complexes responsible for breaking down surplus or damaged proteins, have previously been linked to tight junction degradation, and proteasome inhibitors can prevent degradation of occludin  and ZO-2 . The reduction in proteasome gene expression induced by L. plantarum MB452 may be an additional mechanism by which tight junction integrity is enhanced.
Several of the tight junction-related genes with altered expression induced by L. plantarum MB452 may also be involved in reducing cell proliferation. For example, ZO-1, which had increased gene expression in the presence of L. plantarum MB452, is a 'dual location protein' involved in the regulation of cell proliferation. The ZO-1 protein binds to the CSDA protein (also known as ZONAB) and sequesters it to tight junctions, and removal of the CSDA protein from nucleus in this way results in a reduction in the CDK4 protein . Therefore, an increase in ZO-1 gene expression may lead to a decrease in CDK4 gene expression as seen here (Figure 3), which highlights the link between the formation of tight junctions and a reduction in cell proliferation . Additionally, L. plantarum MB452 reduced the expression of the CPSF2 gene, which encodes a protein which is part of the CSTF-CPSF-SYMPK complex, that regulates cell-cycle related gene expression and promotes cell proliferation . Together with the decreased expression of tubulin genes, these effects of L. plantarum MB452 on the ZO-1, CDK4 and CPSF2 genes may lead to decreased cell proliferation and contribute to the reported anti-proliferative effect of the VSL#3 product .
L. plantarum MB452 did not alter the expression levels of other genes and pathways that have been affected by some probiotic bacteria, such as the NF-κB pathway , PPARγ [40, 41], innate immune response pathway , or human β defensin-2 . This indicates that, unlike some other probiotic bacteria, L. plantarum MB452 does not seem to exert its beneficial effect by regulating host immune responses in healthy intestinal cells.
In this study using L. plantarum MB452 alone, only certain effects previously associated with VSL#3 were observed. VSL#3 is a mixture of L. plantarum, L. casei, L. acidophilus, L. delbrueckii subspecies bulgaricus, B. longum, B. breve, B. infantis and Streptococcus thermophilus, and is likely that each bacterial species has a range of effects. A previous study indicated that of the bacterial strains present in VSL#3, the culture supernatant of B. infantis was associated with the greatest increase in TEER across Caco-2 cells compared to untreated controls . Of the VSL#3 lactobacilli, L. plantarum MB452 produced the supernatant with the greatest effect of TEER, which is in agreement with previous work that showed the beneficial effects of L. plantarum MB452 supernatant . Other studies indicated that the anti-inflammatory effects of VSL#3 are, at least partially, due to VSL#3 bifidobacteria decreasing the abundance of the pro-inflammatory cytokine IL-8  and L. casei in VSL#3 reducing the abundance the pro-inflammatory cytokine interferon gamma-induced protein 10 . The genes encoding for these cytokines were not altered in response to L. plantarum MB452 in the present study.
The data presented in this study shows that a probiotic, L. plantarum MB452, enhanced intestinal barrier function by affecting the expression of genes in the tight junction signalling pathway in health intestinal epithelial cells, in particular the genes encoding occludin and its associated plaque proteins, ZO-1, ZO-2 and cingulin. Further studies will investigate the function of these key genes and evaluate their role in L. plantarum MB452 mediated changes in intestinal barrier function. These results also highlight that changes in intestinal barrier function may also be linked to changes in tubulin and/or proteasome gene expression. Further targeted studies will investigate whether these gene expression changes are important in the observed enhanced intestinal barrier function, and, if so, the mechanisms involved. The long-term aim is to understand the way in which bacteria increase tight junction integrity in order to develop probiotic foods that enhance intestinal barrier function and therefore improve human wellness.
Lactobacillus plantarum MB452  was isolated from VSL#3 (Orphan Australia Pty Ltd, Berwick, Australia). A sachet of VSL#3 powder was suspended in 50 mL of sterile water and the culture was streaked on MRS agar plates (de Man, Rogosa and Sharpe Broth, Difco, Sparks, USA) and incubated aerobically at 30°C, 37°C and 42°C and anaerobically at 37°C. Colony morphologies were recorded and sample colonies from each plate were sub-cultured into Brain Heart Infusion broth (Difco, USA) with 30% glycerol for storage at -85°C. As described in Additional File 2, colonies with similar morphology were compared using pulse-field gel electrophoresis and representatives of each profile were identified based on their 16 s rRNA sequences.
Mammalian cell culture
Caco-2 cell (HTB-37; ATCC) stock cultures were grown in T75 flasks in M199 tissue culture medium with 10% foetal bovine serum (GIBCO, Invitrogen Corporation, Auckland, NZ), 1% non-essential amino acids (MEM non-essential amino acids 100× solution, Sigma-Aldrich, St Louis, USA) and 1% penicillin-streptomycin (10,000 units penicillin G sodium salt and 10000 g streptomycin sulphate in 0.85% saline, GIBCO, Invitrogen Corporation, Auckland, NZ) at 37 C in 5% CO2. The media was replaced every 3 to 4 days and the cells were subcultured weekly at a ratio of 1:3. Caco-2 cells with a passage number of 30 to 35 were used for all experiments.
Trans-epithelial electrical resistance assay
Caco-2 cells were seeded onto 14 mm collagen membrane inserts (Cellagen™ Discs CD-24, MP Biomedicals, Ohio, USA) at a density of 105 cells/insert. Each insert was placed in a well in a 12-well plate with 1 mL of media in the bottom and 250 µL media in the top. The media was replaced every 2 to 3 days. Confluent Caco-2 monolayers (5 days old) were used for the majority of the TEER experiments; except for the TEER experiment done in parallel with the gene expression experiment where differentiated Caco-2 monolayers were used (18 days old). All Caco-2 monolayers had initial TEER values of greater than 300 ohms.cm2. The Caco-2 monolayers were prepared the day before the TEER assay by removing the media, washing three times with PBS and adding M199 with 1% non-essential amino acids (without foetal bovine serum and penicillin-streptomycin) to ensure growth of the bacterial cells. To prepare the bacteria for the TEER assay, an overnight culture of bacterial cells (MRS broth, 37°C, 5% CO2) were collected by centrifugation (12,000 rpm for 5 minutes in a micro centrifuge), washed in phosphate buffered saline (PBS, pH 7.2), and suspended in M199 with 1% non-essential amino acids to the required optical density at 600 nm. After the initial resistance readings were taken on the day of the experiment, the media was removed from the top of the Caco-2 monolayers and replaced with the treatment solutions. For the controls, the spent media was replaced with fresh media (M199 and 1% non-essential amino acids). Each treatment was performed in quadruplicate and each assay was repeated three times.
Every two hours, each insert was lifted into an electrode chamber (ENDOHM-12 tissue culture chamber, World Precision Instruments, Florida, USA) using sterile tweezers and the resistance was measured using a voltohmmeter (EVOM Epithelial Tissue Voltohmmeter, World Precision Instruments, Florida, USA). The TEER was calculated from the resistance using the formula: TEER (Ω cm2) = (resistance (Ω) – background resistance (Ω)) × membrane area (cm2), where the background resistance was 14 and the membrane area was 1.54 cm2. The change in TEER for each insert was calculated using the following formula: change in TEER (%) = TEER (Ω cm2)/initial TEER (Ω.cm2) - 100 (%). The mean change in TEER was plotted against time, with the error bars showing the SEM. Treatments were compared in GenStat (Version 126.96.36.1995) using residual maximum likelihood analysis with an unstructured covariance model to take account of the repeated measures. Statistical differences between treatments were declared at a probability less than 0.05 whilst a probability between 0.05 and 0.1 was considered to represent a trend.
Gene expression analysis
Caco-2 cells were seeded into all wells in 6-well plates at a density of 3 × 105 cells/well. The media was replaced every 3-4 days and the Caco-2 monolayers were grown for 18 days to allow them to differentiate. Six wells were treated with L. plantarum MB452 (OD 600 nm of 0.9) suspended in cell culture media (M199 and 1% non-essential amino acids) and six wells were treated with control media. After 10 hours of exposure (37°C, 5% CO2) the treatment solutions were removed and the monolayers were rinsed with PBS.
The total RNA was extracted from the Caco-2 cells using TRIzol, (Invitrogen, Auckland, New Zealand) and purified using RNeasy mini columns (QIAGEN, San Diego, CA, USA). An equal amount of RNA from three wells of the same treatment was pooled together to yield enough RNA for the gene expression analysis (microarray and qRT-PCR); two control pools and two pools treated with L. plantarum MB452. Equal amounts of RNA from all 12 wells were pooled together to make the reference RNA sample. A similar experimental design previously gave biologically relevant results [48, 49]. RNA samples were labelled, amplified and hybridised to Agilent Technologies 44 k whole human genome oligonucleotide arrays (G4112A) according to the manufacturer's instructions. The Limma package in Bioconductor was used to analyse the microarray data . Genes with a fold change greater than 1.2 and a modified p-value less than 0.05 were considered differentially expressed. Differentially expressed genes were clustered into functional groups and pathways using Ingenuity Pathway Analysis (IPA version 7.1; Ingenuity Systems Inc., Redwood City, CA, USA), and Gene Ontology categories and KEGG pathways using EASE (version 2.0). The raw microarray data have been deposited in the NCBI Gene Expression Omnibus under the GEO accession number GSE18372. Full details of the methods are given in Additional File 3.
The expression of tight junction-related genes differentially expressed from the microarray analysis was confirmed using qRT-PCR. The expression of seven target genes relative to three reference genes was assessed using the standard curve method. The reference genes (GAPD, SDHA and YWHAZ) were chosen based on the findings of Vandesompele et al  and their log ratios in the microarray data (close to 1; not differentially expressed). Five target genes (ZO-1, ZO-2, OCLN, CGN and ACTB) were chosen from the tight junction-related genes that were differentially expressed (all up-regulated) in the microarray analysis. The two other target genes, GJA7 and CLDN3, were chosen to be included because they were down-regulated and not differentially expressed, respectively, in the microarray analysis. The analysis was carried out as described in Additional File 3 and the data was analysed using Relative Expression Software Tool 2008 (version 2.0.7) with efficiency correction .
Caco-2 cells were grown on Lab Tek II Chamber Slides with Permanox™ coating (Nalge Nunc International Corp, Naperville, IL, USA) for 6 days until confluent. Caco-2 cells were treated with L. plantarum MB452 (OD 600 nm 0.9) or control media for 8 hours (n = 4 per treatment per antibody). After treatment, Caco-2 cells were rinsed twice with PBS, fixed in either 4% (w/v) paraformaldehyde for 20 minutes (for CGN and ZO-1) or ice cold 70% ethanol (for ZO-2 and OCLN), quenched with 50 mM NH4Cl (in PBS) for 15 minutes, and blocked with blocking solution (2% (v/v) foetal bovine serum, 1% sheep serum albumin, 0.1% Triton X-100, 0.05% Tween 20 in PBS, pH 7.2) for 20 minutes. Caco-2 cells were then immuno-stained with the primary antibodies (2.5 µg/mL rabbit anti-ZO-1, 1.25 µg/mL rabbit anti-ZO-2, 2.5 µg/mL rabbit anti-occludin, 1 µg/mL rabbit anti-cingulin; Zymed, Invitrogen, NZ) in blocking solution for 1 hour, followed by a PBS wash (0.1% Triton X-100, 0.05% Tween 20 in PBS) to reduce non-specific staining, and the secondary antibody, Alexa Fluor 488 goat anti-rabbit IgG (5 µg/mL for ZO-2, 10 µg/mL for rest; Invitrogen, NZ) in blocking solution for 1 hour. The slides were imaged with a fluorescent microscope (Leica DM2500 microscope, Leica DFC420C camera) with the following settings: exposure 1.1 ms, saturation 2.25, gamma 1.52, gain 8.4× and magnification 40×. The images were viewed using LAS Image Overlay software (Leica Application Suite v1.8.2).
This work was funded by the AgResearch Internal Investment Fund. RCA is funded by a New Zealand Foundation of Research, Science and Technology Postdoctoral Fellowship (AGRX0602). The authors acknowledge the contribution of Kelly Armstrong (fluorescent microscopy) and Paul Maclean (gene ontology and KEGG pathway analysis).
- Bruewer M, Samarin S, Nusrat A: Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci. 2006, 1072: 242-252. 10.1196/annals.1326.017.View ArticlePubMed
- Barbara G: Mucosal barrier defects in irritable bowel syndrome. Who left the door open?. Am J Gastroenterol. 2006, 101 (6): 1295-1298. 10.1111/j.1572-0241.2006.00667.x.View ArticlePubMed
- Guttman JA, Samji FN, Li Y, Vogl AW, Finlay BB: Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect Immun. 2006, 74 (11): 6075-6084. 10.1128/IAI.00721-06.PubMed CentralView ArticlePubMed
- Hart A, Kamm MA: Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther. 2002, 16 (12): 2017-2028. 10.1046/j.1365-2036.2002.01359.x.View ArticlePubMed
- Mullin J, Valenzano M, Verrecchio J, Kothari R: Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats. Dig Dis Sci. 2002, 47 (10): 2262-2270. 10.1023/A:1020191412285.View ArticlePubMed
- Liu Z, Li N, Neu J: Tight junctions, leaky intestines, and pediatric diseases. Acta Paediatr. 2005, 94 (4): 386-393. 10.1111/j.1651-2227.2005.tb01904.x.View ArticlePubMed
- Sandek A, Rauchhaus M, Anker SD, von Haehling S: The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care. 2008, 11 (5): 632-639. 10.1097/MCO.0b013e32830a4c6e.View ArticlePubMed
- Vaarala O, Atkinson MA, Neu J: The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008, 57 (10): 2555-2562. 10.2337/db08-0331.PubMed CentralView ArticlePubMed
- Maes M, Leunis JC: Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol Lett. 2008, 29 (6): 902-910.PubMed
- Maes M: The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett. 2008, 29 (3): 287-291.PubMed
- Farquhar MG, Palade GE: Junctional complexes in various epithelia. J Cell Biol. 1963, 17: 375-412. 10.1083/jcb.17.2.375.PubMed CentralView ArticlePubMed
- Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PS, Goulet J, Tompkins TA: Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun. 2005, 73 (8): 5183-5188. 10.1128/IAI.73.8.5183-5188.2005.PubMed CentralView ArticlePubMed
- Klingberg TD, Pedersen MH, Cencic A, Budde BB: Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol. 2005, 71 (11): 7528-7530. 10.1128/AEM.71.11.7528-7530.2005.PubMed CentralView ArticlePubMed
- Putaala H, Salusjarvi T, Nordstrom M, Saarinen M, Ouwehand AC, Bech-Hansen E, Rautonen N: Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol. 2008, 195 (9-10): 692-698. 10.1016/j.resmic.2008.08.002.View Article
- Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M, Madsen KL: Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol. 2008, 295 (5): G1025-1034. 10.1152/ajpgi.90227.2008.View ArticlePubMed
- Mennigen R, Nolte K, Rijcken EM, Utech M, Loeffler B, Senninger N, Bruewer M: Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol. 2009, 296 (5): G1140-1149. 10.1152/ajpgi.90534.2008.View ArticlePubMed
- Qin H, Zhang Z, Hang X, Jiang Y: L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 2009, 9: 63-10.1186/1471-2180-9-63.PubMed CentralView ArticlePubMed
- Otte JM, Podolsky DK: Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004, 286 (4): G613-626. 10.1152/ajpgi.00341.2003.View ArticlePubMed
- Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D: Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis. 2002, 8 (6): 399-406. 10.1097/00054725-200211000-00004.View ArticlePubMed
- Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M: Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol. 2005, 174 (6): 3237-3246.View ArticlePubMed
- Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR: A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003, 17 (7): 895-904. 10.1046/j.1365-2036.2003.01543.x.View ArticlePubMed
- Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB: VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis. Am J Gastroenterol. 2005, 100 (7): 1539-1546. 10.1111/j.1572-0241.2005.41794.x.View ArticlePubMed
- Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000, 119 (2): 305-309. 10.1053/gast.2000.9370.View ArticlePubMed
- Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, Freitas JR, Boag JM, Cummings AJ, Kees UR: Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?. BMC Genomics. 2005, 6 (1): 59-10.1186/1471-2164-6-59.PubMed CentralView ArticlePubMed
- Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K: Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996, 134 (4): 1031-1049. 10.1083/jcb.134.4.1031.View ArticlePubMed
- Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM: The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998, 273 (45): 29745-29753. 10.1074/jbc.273.45.29745.View ArticlePubMed
- Traweger A, Fang D, Liu YC, Stelzhammer W, Krizbai IA, Fresser F, Bauer HC, Bauer H: The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch. J Biol Chem. 2002, 277 (12): 10201-10208. 10.1074/jbc.M111384200.View ArticlePubMed
- Ikenouchi J, Matsuda M, Furuse M, Tsukita S: Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Cell Sci. 2003, 116 (Pt 10): 1959-1967. 10.1242/jcs.00389.View ArticlePubMed
- Hashimoto K, Oshima T, Tomita T, Kim Y, Matsumoto T, Joh T, Miwa H: Oxidative stress induces gastric epithelial permeability through claudin-3. Biochem Biophys Res Commun. 2008
- Musch MW, Walsh-Reitz MM, Chang EB: Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption. Am J Physiol Gastrointest Liver Physiol. 2006, 290 (2): G222-231. 10.1152/ajpgi.00301.2005. Epub 2005 Oct 2020.View ArticlePubMed
- Panigrahi P, Braileanu GT, Chen H, Stine OC: Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology. World J Gastroenterol. 2007, 13 (47): 6370-6378. 10.3748/wjg.13.6370.PubMed CentralView ArticlePubMed
- Troost FJ, van Baarlen P, Lindsey P, Kodde A, de Vos WM, Kleerebezem M, Brummer RJ: Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo. BMC Genomics. 2008, 9: 374-10.1186/1471-2164-9-374.PubMed CentralView ArticlePubMed
- van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, de Groot PJ, Hooiveld GJ, Brummer RJ, Kleerebezem M: Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci USA. 2009, 106 (7): 2371-2376. 10.1073/pnas.0809919106.PubMed CentralView ArticlePubMed
- Yap AS, Stevenson BR, Abel KC, Cragoe EJ, Manley SW: Microtubule integrity is necessary for the epithelial barrier function of cultured thyroid cell monolayers. Exp Cell Res. 1995, 218 (2): 540-550. 10.1006/excr.1995.1189.View ArticlePubMed
- Lui WY, Lee WM: cAMP perturbs inter-Sertoli tight junction permeability barrier in vitro via its effect on proteasome-sensitive ubiquitination of occludin. J Cell Physiol. 2005, 203 (3): 564-572. 10.1002/jcp.20254.View ArticlePubMed
- Huang W, Eum SY, Andras IE, Hennig B, Toborek M: PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. Faseb J. 2009, 23 (5): 1596-1606. 10.1096/fj.08-121624.PubMed CentralView ArticlePubMed
- Balda MS, Garrett MD, Matter K: The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 2003, 160 (3): 423-432. 10.1083/jcb.200210020.PubMed CentralView ArticlePubMed
- Kavanagh E, Buchert M, Tsapara A, Choquet A, Balda MS, Hollande F, Matter K: Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin. J Cell Sci. 2006, 119 (Pt 24): 5098-5105. 10.1242/jcs.03297.View ArticlePubMed
- Linsalata M, Russo F, Berloco P, Valentini AM, Caruso ML, De Simone C, Barone M, Polimeno L, Di Leo A: Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo. 2005, 19 (6): 989-995.PubMed
- Kelly D, Campbell JI, King TP, Grant GA, Jansson EA, Coutts AGP, Pettersson S, Conway S: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-g and RelA. Nature Immunology. 2004, 5 (1): 104-112. 10.1038/ni1018.View ArticlePubMed
- Voltan S, Martines D, Elli M, Brun P, Longo S, Porzionato A, Macchi V, D'Inca R, Scarpa M, Palu G: Lactobacillus crispatus M247-derived H2O2 acts as a signal transducing molecule activating peroxisome proliferator activated receptor-gamma in the intestinal mucosa. Gastroenterology. 2008, 135 (4): 1216-1227. 10.1053/j.gastro.2008.07.007.View ArticlePubMed
- Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J: The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun. 2008, 76 (9): 4163-4175. 10.1128/IAI.00188-08.PubMed CentralView ArticlePubMed
- Schlee M, Harder J, Koten B, Stange EF, Wehkamp J, Fellermann K: Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol. 2008, 151 (3): 528-535. 10.1111/j.1365-2249.2007.03587.x.PubMed CentralView ArticlePubMed
- Anderson RC, Cassidy LC, Cookson AL, Koulman A, Hurst RD, Fraser K, McNabb WC, Lane G, Roy NC: Identification of commensal bacterial metabolites that enhance the integrity of the gastrointestinal barrier. Proceedings of the New Zealand Society of Animal Production. 2006, 66: 225-229.
- Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology. 2004, 126 (5): 1358-1373. 10.1053/j.gastro.2004.02.003.View ArticlePubMed
- Hormannsperger G, Clavel T, Hoffmann M, Reiff C, Kelly D, Loh G, Blaut M, Holzlwimmer G, Laschinger M, Haller D: Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS ONE. 2009, 4 (2): e4365-10.1371/journal.pone.0004365.PubMed CentralView ArticlePubMed
- Brigidi P, Swennen E, Vitali B, Rossi M, Matteuzzi D: PCR detection of Bifidobacterium strains and Streptococcus thermophilus in feces of human subjects after oral bacteriotherapy and yogurt consumption. Int-J-Food-Microbiol. 2003, 81 (3): 203-209. 10.1016/S0168-1605(02)00245-3.View ArticlePubMed
- Knoch B, Barnett MPG, McNabb W, Park-Ng Z, Zhu ST, Nones K, Dommels Y, Knowles S, Roy NC: Genome-wide analysis of genes involved in eicosapentaenoic acid-induced modulation of colonic inflammation. J Nutrigenetics Nutrigenomics. 2009, 2: 9-28. 10.1159/000134292.View Article
- Chicault C, Toutain B, Monnier A, Aubry M, Fergelot P, Le Treut A, Galibert MD, Mosser J: Iron-related transcriptomic variations in CaCo-2 cells, an in vitro model of intestinal absorptive cells. Physiol Genomics. 2006, 26 (1): 55-67. 10.1152/physiolgenomics.00297.2005.View ArticlePubMed
- Smyth G: Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor. Edited by: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W. 2005, New York: Springer, 397-420. full_text.View Article
- Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol. 2003, 4 (10): R70-10.1186/gb-2003-4-10-r70.PubMed CentralView ArticlePubMed
- Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3 (7): 34-10.1186/gb-2002-3-7-research0034.View Article
- Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30 (9): e36-10.1093/nar/30.9.e36.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.